- PROFESSOR Orthopaedics
Dr. Michael Neuwirth is a Professor of Orthopedics at The Mount Sinai School of Medicine. Prior to moving his practice to Mount Sinai Hospital on January 1, 2013 he was Director of The New York Spine Institute and Director of the fellowship program at Beth Israel Medical Center in New York City.
Prior to joining Beth Israel he was Chief of Spinal Surgery at The Hospital for Joint Diseases in New York City. He is a graduate of SUNY Downstate Medical Center and completed his residency in orthopedics at The Hospital for Joint Diseases. He completed a fellowship in spinal surgery at Presbyterian St. Luke’s Hospital in Chicago. Dr. Neuwirth’s practice is limited exclusively to spinal surgery. His areas of expertise and special interest include Scoliosis, Kyphosis and Spinal Deformity. He also focuses on degenerative conditions of the cervical, thoracic and lumbar spine, including disc herniation, spinal stenosis, spondylolisthesis and myelopathy.
Approximately 30 percent of Dr. Neuwirth’s practice is devoted to revision surgery. He also incorporates the latest advances in minimally invasive surgery to reduce surgical risk and shorten recovery time. He has authored numerous articles and has contributed chapters to many textbooks on spinal surgery. Dr. Neuwirth is the author of THE SCOLIOSIS HANDBOOK, a guide specifically devoted to educating teenagers and adults with scoliosis. Dr. Neuwirth has lectured extensively in the United States and Internationally.
Dr. Neuwirth is currently a member of The North American Spine Society (NASS) and The Scoliosis Research Society (SRS). He is a former board member of the SRS. He has been selected by Castle and Connolly Top Doctors for the New York Metropolitan Area for orthopedic spine surgery for the past 10 years. He has also been selected multiple times for New York Magazine’s Top Doctors. Dr. Neuwirth is one of the most highly respected orthopedic spine surgeons in the Northeast. He has trained over 30 fellows in spinal surgery who have established successful practices throughout the country. They are further testimony to Dr. Neuwirth’s continuing impact on the future of spinal surgery.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Neuwirth did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Faculty Practice Associates Floor 9
5 East 98th Street
New York, NY 10029